PARKINSON DISEASE, IDIOPATHIC
Clinical trials for PARKINSON DISEASE, IDIOPATHIC explained in plain language.
Never miss a new study
Get alerted when new PARKINSON DISEASE, IDIOPATHIC trials appear
Sign up with your email to follow new studies for PARKINSON DISEASE, IDIOPATHIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets genetic form of Parkinson's in Early-Stage trial
Disease control Recruiting nowThis study tests an experimental drug called NEU-411 in 150 people aged 40-80 with early Parkinson's disease who have a specific genetic profile linked to the LRRK2 pathway. Participants will be randomly assigned to receive either NEU-411 or a placebo for about a year, with an op…
Matched conditions: PARKINSON DISEASE, IDIOPATHIC
Phase: PHASE2 • Sponsor: Neuron23 Inc. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Eye movements may reveal Parkinson's progression
Knowledge-focused Recruiting nowThis study follows 30 people with mild-to-moderate Parkinson's disease for up to 7 years. Researchers use a video eye-tracking device to measure how eye movements change over time. The goal is to see if these eye tests can help track the disease and its response to medication.
Matched conditions: PARKINSON DISEASE, IDIOPATHIC
Phase: NA • Sponsor: Association de Recherche Bibliographique pour les Neurosciences • Aim: Knowledge-focused
Last updated May 17, 2026 01:20 UTC